Can We Diagnose Early Melanoma With New Imaging Technologies?
International Journal of Dermatology · 2026
DOI: 10.1111/ijd.70547 ↗At a glance
Übersichtsarbeit in International Journal of Dermatology, 2026. Written by Maximilian Deußing and 1 co-authors. Institution: Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany. Major MEDLINE topics: Melanoma, Skin Neoplasms, Early Detection of Cancer, Multimodal Imaging. Cited 1 times so far (Crossref); 19 references.
Abstract (original language)
Multimodal imaging enables risk‐adapted early melanoma diagnosis by integrating dermoscopy, OCT, in vivo RCM, ex vivo RCM, and LC‐OCT. These technologies provide complementary architectural, cellular, and perioperative information, supporting improved diagnostic precision while reducing unnecessary excisions in equivocal melanocytic lesions. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany.
- Department of Dermatology and Allergy, Munich Municipal Hospital, Munich, Germany.
ORCID profiles: Maximilian Deußing
Cite
APA
Deußing, M., & Hartmann, D. (2026). Can We Diagnose Early Melanoma With New Imaging Technologies?. International Journal of Dermatology. https://doi.org/10.1111/ijd.70547
Vancouver
Deußing M, Hartmann D. Can We Diagnose Early Melanoma With New Imaging Technologies?. International Journal of Dermatology. 2026. doi:10.1111/ijd.70547
BibTeX
@article{Deuing2026,
author = {Deußing, Maximilian and Hartmann, Daniela},
title = {Can We Diagnose Early Melanoma With New Imaging Technologies?},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70547}
}
EUVIMED